(R)-2-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carbonyl)piperazin-1-yl)acetic acid | 1615700-24-7

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (R)-2-(4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-carbonyl)piperazin-1-yl)acetic acid
• 英文别名: 2-[4-[(2R)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromene-2-carbonyl]piperazin-1-yl]acetic acid
• CAS: 1615700-24-7
• 化学式: C₂₀H₂₈N₂O₅
• 分子量: 376.453
• InChiKey: LXPYRDXEWHBDJU-HXUWFJFHSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -0.1
• 重原子数：
  27
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.6
• 拓扑面积：
  90.3
• 氢给体数：
  2
• 氢受体数：
  6

文献信息

• [EN] 6-HYDROXY-2,5,7,8-TETRAMETHYLCHROMAN-COMPOUNDS FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE AIRWAY DISEASES<br/>[FR] COMPOSÉS 6-HYDROXY-2,5,7,8-TETRAMÉTHYLCHROMAN- POUR LE TRAITEMENT DE MALADIES OBSTRUCTIVES CHRONIQUES DES VOIES RESPIRATOIRES
  申请人：SULFATEQ BV

  公开号：WO2015193365A1

  公开（公告）日：2015-12-23

  The present invention relates to compounds for the treatment of chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis. The present invention further relates to drug delivery devices suitable to be used in the treatment of chronic obstructive airway diseases such as a nebulizer comprising the present compounds. Specifically, the present invention relates to (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the treatment of chronic obstructive airway diseases, preferably chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis, more preferably chronic obstructive pulmonary disease (COPD).

  本发明涉及用于治疗慢性阻塞性气道疾病，如慢性阻塞性肺病（COPD）或哮喘或支气管扩张症的化合物。本发明还涉及适用于治疗慢性阻塞性气道疾病的药物给药装置，例如包含本发明化合物的雾化器。具体地，本发明涉及用于治疗慢性阻塞性气道疾病，尤其是慢性阻塞性肺病（COPD）或哮喘或支气管扩张症的（6-羟基-2,5,7,8-四甲基色素-2-基）（哌嗪-1-基）甲酮或N,6-二羟基-2,5,7,8-四甲基色素-2-甲酰胺或其药用可接受的盐或碱。
• COMPOUNDS FOR PROTECTION OF CELLS
  申请人：SULFATEQ B.V.

  公开号：US20150342174A1

  公开（公告）日：2015-12-03

  This invention is related to a compound with the structural formula (I) wherein, R1, and R2 are independently selected from the group consisting of C 1 -C 6 alkyl and is preferably methyl, ethyl, propyl or isopropyl; R3 is selected from the group consisting of CH 2 NHR 9 , C(═O)YR 10 , —CH2OH

  本发明涉及一种化合物，其结构式为(I)，其中R1和R2独立地选自C1-C6烷基群，最好是甲基、乙基、丙基或异丙基；R3选自CH2NHR9、C(═O)YR10、—CH2OH群。
• Compounds for protection of cells
  申请人：SULFATEQ B.V.

  公开号：US10123529B2

  公开（公告）日：2018-11-13

  This invention is related to a compound with the structural formula (I) wherein, R1, and R2 are independently selected from the group consisting of C1-C6 alkyl and is preferably methyl, ethyl, propyl or isopropyl; R3 is selected from the group consisting of CH2NHR9, C(═O)YR10, —CH2OH

  本发明涉及一种结构式为 (I) 的化合物 其中 R1 和 R2 独立地选自 C1-C6 烷基组成的组，最好是甲基、乙基、丙基或异丙基； R3 选自 CH2NHR9、C(═O)YR10、-CH2OH 所组成的组
• 6-hydroxy-2,5,7,8-tetramethylchroman-compounds for the treatment of chronic obstructive airway diseases
  申请人：Sulfateq B.V.

  公开号：US10322124B2

  公开（公告）日：2019-06-18

  The present invention relates to compounds for the treatment of chronic obstructive airway diseases such as chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis. The present invention further relates to drug delivery devices suitable to be used in the treatment of chronic obstructive airway diseases such as a nebulizer comprising the present compounds. Specifically, the present invention relates to (6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the treatment of chronic obstructive airway diseases, preferably chronic obstructive pulmonary disease (COPD) or asthma or bronchiectasis, more preferably chronic obstructive pulmonary disease (COPD).

  本发明涉及用于治疗慢性阻塞性气道疾病如慢性阻塞性肺病（COPD）或哮喘或支气管扩张的化合物。本发明进一步涉及适用于治疗慢性阻塞性气道疾病的给药装置，如包含本发明化合物的雾化器。 具体而言，本发明涉及用于治疗慢性阻塞性气道疾病的(6-羟基-2,5,7,8-四甲基苯并二氢吡喃-2-基)(哌嗪-1-基)甲酮或 N,6-二羟基-2,5,7,8-四甲基苯并二氢吡喃-2-甲酰胺或其药学上可接受的盐或碱、优选慢性阻塞性肺病（COPD）或哮喘或支气管扩张症，更优选慢性阻塞性肺病（COPD）。
• Compound for the prophylaxis or treatment of organ damage
  申请人：Sulfateq B.V.

  公开号：US10676452B2

  公开（公告）日：2020-06-09

  The present invention relates to compounds for prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially to compounds for prophylaxis or treatment of diabetic kidney damage. Specifically, the present invention relates to 6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone or N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide or a pharmaceutically acceptable salt or base thereof for use in the prophylaxis or treatment of organ damage by restoring endothelial function and/or inhibiting reactive oxygen species production and especially diabetic kidney organ damage.

  本发明涉及通过恢复内皮功能和/或抑制活性氧生成来预防或治疗器官损伤的化合物，尤其涉及预防或治疗糖尿病肾损伤的化合物。具体地说，本发明涉及6-羟基-2,5,7,8-四甲基苯并二氢吡喃-2-基)(哌嗪-1-基)甲酮或N,6-二羟基-2,5,7,8-四甲基苯并二氢吡喃-2-甲酰胺或其药学上可接受的盐或碱，用于通过恢复内皮功能和/或抑制活性氧的产生，特别是糖尿病肾脏器官损伤的预防或治疗。